ArticlemBio2025
Metagenomic analysis after selective culture enrichment of hospital and community wastewater enhances antimicrobial resistance gene detection.
Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrated qPCR and Shotgun Metagenomics for Surveillance of Antimicrobial Resistance in Municipal Wastewater from Central Italy.Antibiotics (Basel, Switzerland) · 2026Article
- Hospital Air and Healthcare Personnel as Reservoirs of Drug-Resistant Bacteria in Tertiary Care Settings in Pakistan.Infection and drug resistance · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Antimicrobial resistance is an accelerating threat to global health. Wastewater-based surveillance (WBS) enables objective, inclusive, and comprehensive assessments of population-level antimicrobial resistance; however, it is limited in its ability to detect rare antibiotic resistance genes (ARG). We compared traditional high-depth metagenomic sequencing of raw wastewater with lower-depth sequencing following semi-selective culture enrichment for gram negatives for rare ARGs in wastewater from two tertiary-care hospitals and two nearby urban neighborhoods. In total, 26 antibiotic resistance gene types (1,225 subtypes) were identified, with beta-lactamase genes being the most prevalent. Resistomes differed between raw and culture-enriched wastewater metagenomes and clustered based on sample type (hospitals versus neighborhoods). Hospital wastewater had higher diversity and a greater abundance of ARGs relative to both raw and culture-enriched neighborhood wastewater metagenomes. Lower coverage sequencing following culture enrichment proved superior to deeper sequencing for identifying rare, clinically relevant targets, including carbapenemase genes. In particular, enrichment with meropenem proved the most sensitive to identifying clinically relevant genes and enabled significant cost savings. ARG WBS has enormous potential for augmenting hospital-based infection prevention and control and antimicrobial stewardship programs.IMPORTANCEAntimicrobial resistance (AMR) poses a considerable burden to healthcare systems and contributes to increased morbidity and mortality. This is expected to further increase with time. AMR surveillance programs are key to understanding and controlling this progressive threat. Wastewater-based surveillance (WBS) is an emerging tool that can be adapted to this end. This study explores the role of metagenomic analysis of WBS with/and without culture enrichment to detect rare antibiotic resistance genes (ARG) of clinically important pathogens across a range of scales. We were able to demonstrate that the resistome of hospitals significantly differs from communities having a greater abundance, and more heterogeneous ARGs. Culture enrichment, particularly with meropenem, improved the detection of clinically relevant ARGs even at lower sequencing depths. WBS is an important tool with the capacity to augment hospital-based infection control and antimicrobial stewardship programs, providing real-time, cost-effective information on the population within.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.